Centralized databases enhance drug safety monitoring by enabling real-time data access, improving signal detection, and ensuring regulatory compliance across global pharmacovigilance systems efficiently and accurately.

Effective drug safety monitoring relies on optimized data collection processes to ensure accurate adverse event reporting.